A US study found a new way in which breast cancer becomes resistant to tamoxifen, the most widely sold drug for breast cancer prevention and treatment throughout the world. The researchers suggest this could be an early way to spot patients who are not responding to tamoxifen and give doctors time to find an alternative treatment sooner.
More...